Analysis of Lenvatinib’s Efficacy against Intermediate-Stage Unresectable Hepatocellular Carcinoma

SIMPLE SUMMARY: With the emergence of the concepts of transarterial chemoembolization (TACE) refractoriness and unsuitability and recent advances in systemic therapy, treatment options for intermediate-stage, unresectable hepatocellular carcinoma (u-HCC) are increasing. However, the efficacy of lenv...

Descripción completa

Detalles Bibliográficos
Autores principales: Amioka, Kei, Kawaoka, Tomokazu, Kinami, Takahiro, Yamasaki, Shintaro, Kosaka, Masanari, Johira, Yusuke, Yano, Shigeki, Naruto, Kensuke, Ando, Yuwa, Fujii, Yasutoshi, Uchikawa, Shinsuke, Ono, Atsushi, Yamauchi, Masami, Imamura, Michio, Kosaka, Yumi, Ohya, Kazuki, Mori, Nami, Takaki, Shintaro, Tsuji, Keiji, Masaki, Keiichi, Honda, Yoji, Kouno, Hirotaka, Kohno, Hioshi, Morio, Kei, Moriya, Takashi, Naeshiro, Noriaki, Nonaka, Michihiro, Aisaka, Yasuyuki, Azakami, Takahiro, Hiramatsu, Akira, Aikata, Hiroshi, Oka, Shiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600304/
https://www.ncbi.nlm.nih.gov/pubmed/36291850
http://dx.doi.org/10.3390/cancers14205066

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600304/
https://www.ncbi.nlm.nih.gov/pubmed/36291850
http://dx.doi.org/10.3390/cancers14205066

Ejemplares similares